Literature DB >> 22168363

Exploring N-imidazolyl-O-carboxymethyl chitosan for high performance gene delivery.

Bingyang Shi1, Zheyu Shen, Hu Zhang, Jingxiu Bi, Sheng Dai.   

Abstract

Chitosan shows good biocompatibility and biodegradability, but the poor water solubility and low transfection efficiency hinder its applications as a gene delivery vector. We here report the detailed synthesis and characterization of a novel ampholytical chitosan derivative, N-imidazolyl-O-carboxymethyl chitosan (IOCMCS), used for high performance gene delivery. After chemical modification, the solubility of the resulting polymer is enhanced, and the polymer is soluble in a wide pH range (4-10). Gel electrophoresis study reveals the strong binding ability between plasmid DNA and the IOCMCS. Moreover, the IOCMCS does not induce remarkable cytotoxicity against human embryonic kidney (HEK293T) cells. The cell transfection results with HEK293T cells using the IOCMCS as gene delivery vector demonstrate the high transfection efficiency, which is dependent on the degree of imidazolyl substitution. Therefore, the IOCMCS is a promising candidate as the DNA delivery vector in gene therapy due to its high solubility, high gene binding capability, low cytotoxicity, and high gene transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22168363     DOI: 10.1021/bm201380e

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  9 in total

1.  Architectural layer-by-layer assembly of drug nanocapsules with PEGylated polyelectrolytes.

Authors:  Tatsiana G Shutava; Pravin P Pattekari; Kirill A Arapov; Vladimir P Torchilin; Yuri M Lvov
Journal:  Soft Matter       Date:  2012-06-25       Impact factor: 3.679

Review 2.  A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.

Authors:  Adarsha Koirala; Shannon M Conley; Muna I Naash
Journal:  Biomaterials       Date:  2013-06-22       Impact factor: 12.479

Review 3.  Biosafe nanoscale pharmaceutical adjuvant materials.

Authors:  Shubin Jin; Shengliang Li; Chongxi Wang; Juan Liu; Xiaolong Yang; Paul C Wang; Xin Zhang; Xing-Jie Liang
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

4.  Physiochemical, optical and biological activity of chitosan-chromone derivative for biomedical applications.

Authors:  Santosh Kumar; Joonseok Koh
Journal:  Int J Mol Sci       Date:  2012-05-18       Impact factor: 6.208

5.  Evaluation of plasmid DNA stability against ultrasonic shear stress and its in vitro delivery efficiency using ionic liquid [Bmim][PF6].

Authors:  Satya Ranjan Sarker; Andrew S Ball; Suresh K Bhargava; Sarvesh K Soni
Journal:  RSC Adv       Date:  2019-09-17       Impact factor: 4.036

Review 6.  Progress in Research of Chitosan Chemical Modification Technologies and Their Applications.

Authors:  Qizhou Chen; Yi Qi; Yuwei Jiang; Weiyan Quan; Hui Luo; Kefeng Wu; Sidong Li; Qianqian Ouyang
Journal:  Mar Drugs       Date:  2022-08-21       Impact factor: 6.085

Review 7.  Nanomaterial-based encapsulation for controlled gastrointestinal delivery of viable probiotic bacteria.

Authors:  Seyedehhamideh Razavi; Sajjad Janfaza; Nishat Tasnim; Deanna L Gibson; Mina Hoorfar
Journal:  Nanoscale Adv       Date:  2021-03-30

8.  Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate.

Authors:  Xiu Liang Zhu; Yong Zhong Du; Ri Sheng Yu; Ping Liu; Dan Shi; Ying Chen; Ying Wang; Fang Fang Huang
Journal:  Int J Mol Sci       Date:  2013-07-29       Impact factor: 5.923

9.  Synergistic antioxidant capacity of CsNPs and CurNPs against cytotoxicity, genotoxicity and pro-inflammatory mediators induced by hydroxyapatite nanoparticles in male rats.

Authors:  Israa F Mosa; Mokhtar Youssef; Maher Kamel; Osama F Mosa; Yasser Helmy
Journal:  Toxicol Res (Camb)       Date:  2019-10-22       Impact factor: 3.524

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.